Mechanisms of systemic vasculitis

Drug Discovery Today: Disease Mechanisms

Volumn 1, Issue 3, 2004, Pages 297-302

  Manfredi, Angelo A ^a   Sabbadini, Maria Grazia ^a   Ferri, Luca ^a   Bianchi, Marco E ^a   Rovere Querini, Patrizia ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; HIGH MOBILITY GROUP B1 PROTEIN; INFLIXIMAB; MATRIX METALLOPROTEINASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENTRAXIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STEROID;

BLOOD VESSEL WALL; CELL DEATH; CELL INFILTRATION; CHEMOTAXIS; ENVIRONMENTAL FACTOR; GIANT CELL ARTERITIS; HEREDITY; HOMEOSTASIS; HUMAN; LEUKOCYTE; MACROPHAGE; NITRATION; NONHUMAN; PEROXIDATION; PHAGOCYTOSIS; REVIEW; SYSTEMIC VASCULITIS; T LYMPHOCYTE ACTIVATION;

EID: 23744504994     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.11.010     Document Type: Review

References (40)

1. Huugen, D. et al. (2004) Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models. Curr. Opin. Rheumatol. 16, 4-8
2. Harper, L. et al. (2004) The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis. Biochem. Soc. Trans. 32 (Pt 3), 502-506
3. Weyand, C.M. et al. (2004) Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun. Rev. 3, 46-53
4. Seo, P. and Stone, J.H. (2004) The antineutrophil cytoplasmic antibody-associated vasculitides. Am. J. Med. 117, 39-50
5. Seo, P. and Stone, J.H. (2004) Large-vessel vasculitis. Arthritis Rheum. 51, 128-139
6. Cantini, F. et al. (2004) Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin. Arthritis Rheum. 33, 294-301
7. Midwood, K.S. et al. (2004) Tissue repair and the dynamics of the extracellular matrix. Int. J. Biochem. Cell Biol. 36, 1031-1037
8. deCathelineau, A.M. and Henson, P.M. (2003) The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem. 39, 105-117
9. Gregory, C.D. and Devitt, A. (2004) The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113, 1-14
10. Hart, S.P. et al. (2004) Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement. Clin. Exp. Immunol. 135, 181-185
11. Bianchi, M.E. and Manfredi, A. (2004) Chromatin and cell death. Biochim. Biophys. Acta (BBA): Gene Struct. Expr. 1677, 181-186
12. Bianchi, M.E. (2004) Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol. 14, 287-293
13. Savill, J. et al. (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2, 965-975
14. Rovere-Querini, P. and Dumitriu, I.E. (2003) Corpse disposal after apoptosis. Apoptosis 8, 469-479
15. Manfredi, A.A. et al. (2002) The disposal of dying cells in living tissues. Apoptosis 7, 153-161
16. Roos, A. et al. (2004) Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur. J. Immunol. 34, 921-929
17. Steinman, R.M. et al. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711
18. Ma-Krupa, W. et al. (2004) Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J. Exp. Med. 199, 173-183
19. Clayton, A.R. et al. (2003) Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum. 48, 2362-2374
20. Shi, Y. et al. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516-521 (Epub 2003, September 2007)
21. Rovere-Querini, P. et al. (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5, 825-830
22. Messmer, D. et al. (2004) High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173, 307-313
23. Mantovani, A. et al. (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23, 337-366
24. Ulloa, L. et al. (2003) High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis. Arthritis Rheum. 48, 876-881
25. Degryse, B. et al. (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152, 1197-1206
26. Palumbo, R. et al. (2004) Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164, 441-449 (Epub 2004, January 2026)
27. Clementi, E. et al. (2003) Interactions between nitric oxide and sphingolipids and the potential consequences in physiology and pathology. Trends Pharmacol. Sci. 24, 518-523
28. Perrotta, C. et al. (2004) Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma. Cancer Res. 64, 3767-3771
29. Heasman, S.J. et al. (2004) Interferon gamma suppresses glucocorticoid augmentation of macrophage clearance of apoptotic cells. Eur. J. Immunol. 34, 1752-1761
30. Van Rossum, A.P. et al. (2004) Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies. J. Leukoc. Biol. 26, 26
31. van der Geld, Y.M. et al. (2002) Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis. Clin. Exp. Immunol. 129, 562-570
32. Mantovani, A. et al. (2003) Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 21 (Suppl. 2), S43-S47
33. Fazzini, F. et al. (2001) PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 44, 2841-2850
34. Rusnati, M. et al. (2004) Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 104, 92-99 (Epub 2004, March 2018)
35. Rovere, P. et al. (2000) The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96, 4300-4306
36. van Rossum, A.P. et al. (2004) The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum. 50, 2667-2674
37. Bondanza, A. et al. (2004) Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum. 50, 1549-1560
38. Bondanza, A. et al. (2003) Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J. Immunol. 170, 24-27
39. Manfredi, A.A. et al. Dendritic cells and the shadow line between autoimmunity and disease. Arthritis Rheum. (in press)
40. Brinkmann, V. et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535